Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Lesion”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,011
Large-scale testing (Phase 3)Study completedNCT02792231
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Relapsing Multiple Scelrosis
Novartis Pharmaceuticals 955
Testing effectiveness (Phase 2)Ended earlyNCT03363763
What this trial is testing

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Who this might be right for
Angiofibroma of FaceTuberous Sclerosis
Aucta Pharmaceuticals, Inc 24
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Not applicableStudy completedNCT05426980
What this trial is testing

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
University of Ljubljana 654
Not applicableWithdrawnNCT02419638
What this trial is testing

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital
Not applicableStudy completedNCT01628315
What this trial is testing

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
University at Buffalo 159
Not applicableStudy completedNCT03651362
What this trial is testing

Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis

Who this might be right for
Optic Neuritis
University Hospital, Lille 46
Not applicableActive Not RecruitingNCT07235644
What this trial is testing

Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
MS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (Relapsing Remitting)
Uppsala University 184
Not applicableLooking for participantsNCT06955832
What this trial is testing

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Who this might be right for
Multiple Sclerosis
Benha University 30
Not applicableNot Yet RecruitingNCT07444047
What this trial is testing

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Cerebral Small Vessel Diseases
Oslo University Hospital 1,000
Not applicableLooking for participantsNCT04906928
What this trial is testing

Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

Who this might be right for
Spinal Cord Injuries
Fondation Ophtalmologique Adolphe de Rothschild 200
Not applicableLooking for participantsNCT04819737
What this trial is testing

Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

Who this might be right for
Multiple Sclerosis (MS)
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT03268096
What this trial is testing

Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination

Who this might be right for
Multiple SclerosisPathologic ProcessesTomography, Optical Coherence+2 more
Fondation Ophtalmologique Adolphe de Rothschild 182
Large-scale testing (Phase 3)Study completedNCT03315923
What this trial is testing

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Isfahan University of Medical Sciences 84
Not applicableStudy completedNCT04220814
What this trial is testing

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rennes University Hospital 94
Load More Results